Topical Retinoids for Pigmented Skin

May 2011 | Volume 10 | Issue 5 | Original Article | 483 | Copyright © May 2011


Aanand N. Geria MD, Christina N. Lawson MD, Rebat M. Halder MD

Department of Dermatology, Howard University College of Medicine, Washington, DC

  1. Grimes PE. Management of Hyperpigmentation in Darker Racial Ethnic Groups. Semin Cutan Med Surg. 2009;28:77-85.
  2. Stratigos AJ, Katsambas A. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients. Am J Clin Dermatol. 2004;5:161-168.
  3. Morelli J, Norris D. Influence of inflammatory mediators and cytokines in human melanocyte function. J Invest Dermatol. 1993;100:191S-195S.
  4. Bulengo-Ransby SM, Griffiths C, Kimbrough-Green C, Finkel LJ, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Eng J Med. 1993;328:1438-1443.
  5. Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: A double-blind, randomized, vehicle-controlled study. Cutis. 2006;77:45-50.
  6. Taylor SC. Utilizing Combination Therapy for Ethnic Skin. Cutis. 2007;80:15-20.
  7. Kurita M, Kato H, Yoshimura K. A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians. J Plast Reconstr Aesthet Surg. 2009;62:955-963.
  8. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-1457.
  9. Kimbrough-Green CK, Griffiths C, Finkel L, Hamilton TA, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-733.
  10. Kligman A, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40-48.
  11. Grimes P, Kelly A, Torok H, Willis I. Community-Based Trial of a Triple-Combination Agent for the Treatment of Facial Melasma. Cutis. 2006;77:177-184.
  12. Cestari TF, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol. 2007;6:36-39.
  13. Chan R, Park K, Lee M, Lee ES, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159:697-703.
  14. Taylor SC, Torok H, Jones T, Lowe N, et al. Efficacy and Safety of a New Triple-Combination Agent for the Treatment of Facial Melasma. Cutis. 2003;72:67-72.
  15. Nanda S, Grover C, Reddy B. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. Dermatol Surg. 2004;30:385-388.
  16. Kligman A, Fulton J, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol. 1969;99:469-476.
  17. Callender VD. Considerations for Treating Acne in Ethnic Skin. Cutis. 2005;76:19-23.
  18. Halder RM, Holmes Y, Bridgeman-Shah S, Kligman A. A clinicohistopathologic study of acne vulgaris in black females. J Invest Dermatol. 1996;106:888.
  19. Jacyk W. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):37-42.
  20. Czernielewski J, Poncet M, Mizzi F. Efficacy and Cutaneous Safety of Adapalene in Black Patients Versus White Patients With Acne Vulgaris. Cutis. 2002;70:243-248.
  21. Kawashima M, Harada S, Loesche C, Miyachi Y. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris:A randomized, multicenter, investigator-blinded, controlled study. J Dermatol Sci. 2008;49:241-248.
  22. Zhu X-J, Tu P, Zhen J, YQ D. Adapalene gel 0.1%: Effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis. 2001;68:55-59.
  23. Saple DG, Torsekar RG, Pawanarkar V, Dhanalaskshmi UR, et al. An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris. Indian J Dermatol Venereol Leprol. 2004;70:92-95.
  24. Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol. 2000;43(2 Pt 3):51-54.
  25. Guenther L. Tazarotene combination treatments in psoriasis. J Am Acad Dermatol. 2000;43:S36-42.
  26. Angelo JS, Kar B, Thomas J. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: A double-blind, randomized,right-left comparison study. Indian J Dermatol Venereol Leprol. 2007;73:65.
  27. Griffiths CEM, Russman A, Majmudar G, Singer R, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329:530-535.
  28. Kligman A, Grove GH, R, Leyden J. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15:836-859.
  29. Griffiths CEM, Goldfarb M, Finkel L, Roulia V, et al. Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: A vehicle-controlled trial. J Am Acad Dermatol. 1994;30(1):76-84.
  30. Perry PK, Cook-Bolden FE, Rahman Z, Jones E, et al. Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends. J Am Acad Dermatol. 2002;46(suppl 2):113-119.
  31. Halder RM. Pseudofolliculitis barbae and related disorders. Dermatol Clin. 1988;6:407-412.
  32. Taylor SC. Enhancing the care and treatment of skin of color, part 1: The broad scope of pigmentary disorders. Cutis. 2005;76:249-255.
  33. Abergel RP, Meeker CA, Oikarinen H, Oikarinen AI, et al. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol. 1985;121:632-635.
  34. Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol. 1988;14:1275-1276.
  35. Janssen de Limpens AM. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol. 1980;103:319-323.
  36. Foy V, Weinkauf R, Whittle E, Basketter DA. Ethnic variation in the skin irritation response . Contact Dermatitis. 2001;45:346-349.
  37. Callender VD, Preston N, Osborn C, Johnson L, et al. A Meta-Analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne. J Clin Aesthet Dermatol. 2010;3(8):15-19.
Close Menu